nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.0636	0.136	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.046	0.0985	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.046	0.0985	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—AKR1B10—uterine cancer	0.0416	0.0891	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—AKR1C1—uterine cancer	0.0284	0.0608	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.0275	0.0589	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—AKR1C3—uterine cancer	0.0218	0.0468	CbGpPWpGaD
Gentamicin—Venous thrombosis—Carboplatin—uterine cancer	0.0216	0.0437	CcSEcCtD
Gentamicin—LRP2—Diseases associated with visual transduction—AKR1B10—uterine cancer	0.0212	0.0455	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of steroid hormones and vitamin D—CYP19A1—uterine cancer	0.0202	0.0434	CbGpPWpGaD
Gentamicin—Benign intracranial hypertension—Medroxyprogesterone Acetate—uterine cancer	0.0189	0.0382	CcSEcCtD
Gentamicin—Fluid overload—Carboplatin—uterine cancer	0.0187	0.0379	CcSEcCtD
Gentamicin—LRP2—epithelium—uterine cancer	0.0148	0.374	CbGeAlD
Gentamicin—LRP2—Diseases associated with visual transduction—AKR1C1—uterine cancer	0.0145	0.031	CbGpPWpGaD
Gentamicin—LRP2—renal system—uterine cancer	0.0137	0.347	CbGeAlD
Gentamicin—Extravasation—Carboplatin—uterine cancer	0.0133	0.027	CcSEcCtD
Gentamicin—LRP2—Diseases associated with visual transduction—AKR1C3—uterine cancer	0.0112	0.0239	CbGpPWpGaD
Gentamicin—LRP2—female reproductive system—uterine cancer	0.011	0.278	CbGeAlD
Gentamicin—LRP2—Vitamin B12 Metabolism—MTHFR—uterine cancer	0.0107	0.023	CbGpPWpGaD
Gentamicin—Venous thrombosis—Medroxyprogesterone Acetate—uterine cancer	0.0103	0.0208	CcSEcCtD
Gentamicin—Phlebitis—Carboplatin—uterine cancer	0.00981	0.0199	CcSEcCtD
Gentamicin—Laryngeal oedema—Medroxyprogesterone Acetate—uterine cancer	0.00863	0.0175	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—CCL2—uterine cancer	0.0084	0.018	CbGpPWpGaD
Gentamicin—Neurotoxicity—Etoposide—uterine cancer	0.00807	0.0163	CcSEcCtD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—PIK3CA—uterine cancer	0.00797	0.0171	CbGpPWpGaD
Gentamicin—Hepatomegaly—Medroxyprogesterone Acetate—uterine cancer	0.00783	0.0159	CcSEcCtD
Gentamicin—Pulmonary fibrosis—Etoposide—uterine cancer	0.00711	0.0144	CcSEcCtD
Gentamicin—Injection site pain—Medroxyprogesterone Acetate—uterine cancer	0.00679	0.0137	CcSEcCtD
Gentamicin—Hypocalcaemia—Progesterone—uterine cancer	0.00668	0.0135	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00652	0.014	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—AKT1—uterine cancer	0.00651	0.0139	CbGpPWpGaD
Gentamicin—Hepatomegaly—Dactinomycin—uterine cancer	0.00611	0.0124	CcSEcCtD
Gentamicin—Nephropathy toxic—Etoposide—uterine cancer	0.00545	0.011	CcSEcCtD
Gentamicin—Vascular purpura—Progesterone—uterine cancer	0.00496	0.0101	CcSEcCtD
Gentamicin—Extravasation—Dactinomycin—uterine cancer	0.00495	0.01	CcSEcCtD
Gentamicin—Hypocalcaemia—Dactinomycin—uterine cancer	0.00472	0.00956	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00471	0.0101	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00471	0.0101	CbGpPWpGaD
Gentamicin—Visual disturbance—Progesterone—uterine cancer	0.00469	0.00949	CcSEcCtD
Gentamicin—Purpura—Progesterone—uterine cancer	0.00461	0.00933	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Progesterone—uterine cancer	0.00459	0.00929	CcSEcCtD
Gentamicin—Neurotoxicity—Epirubicin—uterine cancer	0.00452	0.00916	CcSEcCtD
Gentamicin—Visual disturbance—Medroxyprogesterone Acetate—uterine cancer	0.00425	0.0086	CcSEcCtD
Gentamicin—Neurotoxicity—Doxorubicin—uterine cancer	0.00419	0.00848	CcSEcCtD
Gentamicin—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.00417	0.00845	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.00416	0.00842	CcSEcCtD
Gentamicin—Numbness—Etoposide—uterine cancer	0.00377	0.00764	CcSEcCtD
Gentamicin—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00366	0.00742	CcSEcCtD
Gentamicin—Phlebitis—Dactinomycin—uterine cancer	0.00364	0.00738	CcSEcCtD
Gentamicin—Sensory loss—Etoposide—uterine cancer	0.00361	0.00731	CcSEcCtD
Gentamicin—Extravasation—Etoposide—uterine cancer	0.00359	0.00726	CcSEcCtD
Gentamicin—Muscular weakness—Medroxyprogesterone Acetate—uterine cancer	0.00355	0.00719	CcSEcCtD
Gentamicin—Weight decreased—Progesterone—uterine cancer	0.00347	0.00703	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00346	0.00741	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Progesterone—uterine cancer	0.00335	0.00679	CcSEcCtD
Gentamicin—Body temperature increased—Carboplatin—uterine cancer	0.00328	0.00665	CcSEcCtD
Gentamicin—Venous thrombosis—Epirubicin—uterine cancer	0.00325	0.00658	CcSEcCtD
Gentamicin—Lethargy—Dactinomycin—uterine cancer	0.0032	0.00649	CcSEcCtD
Gentamicin—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00315	0.00637	CcSEcCtD
Gentamicin—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00304	0.00615	CcSEcCtD
Gentamicin—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.00302	0.00612	CcSEcCtD
Gentamicin—Venous thrombosis—Doxorubicin—uterine cancer	0.00301	0.00609	CcSEcCtD
Gentamicin—Visual impairment—Progesterone—uterine cancer	0.00296	0.00599	CcSEcCtD
Gentamicin—LRP2—Metabolism—NDUFB11—uterine cancer	0.0029	0.00622	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SRD5A2—uterine cancer	0.0029	0.00622	CbGpPWpGaD
Gentamicin—Tinnitus—Progesterone—uterine cancer	0.00286	0.0058	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.00282	0.00604	CbGpPWpGaD
Gentamicin—Hypomagnesaemia—Epirubicin—uterine cancer	0.00276	0.00559	CcSEcCtD
Gentamicin—Alopecia—Progesterone—uterine cancer	0.00271	0.0055	CcSEcCtD
Gentamicin—LRP2—Disease—AKR1B10—uterine cancer	0.0027	0.00578	CbGpPWpGaD
Gentamicin—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.00268	0.00543	CcSEcCtD
Gentamicin—Erythema—Progesterone—uterine cancer	0.00267	0.00542	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.00266	0.00571	CbGpPWpGaD
Gentamicin—Phlebitis—Etoposide—uterine cancer	0.00264	0.00534	CcSEcCtD
Gentamicin—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.0026	0.00526	CcSEcCtD
Gentamicin—Hypomagnesaemia—Doxorubicin—uterine cancer	0.00255	0.00517	CcSEcCtD
Gentamicin—Hepatomegaly—Epirubicin—uterine cancer	0.00248	0.00502	CcSEcCtD
Gentamicin—Anaemia—Progesterone—uterine cancer	0.00247	0.005	CcSEcCtD
Gentamicin—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00246	0.00498	CcSEcCtD
Gentamicin—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00242	0.00491	CcSEcCtD
Gentamicin—Vertigo—Progesterone—uterine cancer	0.0024	0.00487	CcSEcCtD
Gentamicin—Stomatitis—Dactinomycin—uterine cancer	0.00236	0.00477	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Etoposide—uterine cancer	0.00235	0.00475	CcSEcCtD
Gentamicin—Convulsion—Progesterone—uterine cancer	0.00232	0.00469	CcSEcCtD
Gentamicin—Hypertension—Progesterone—uterine cancer	0.00231	0.00468	CcSEcCtD
Gentamicin—Hepatomegaly—Doxorubicin—uterine cancer	0.00229	0.00464	CcSEcCtD
Gentamicin—Arthralgia—Progesterone—uterine cancer	0.00228	0.00461	CcSEcCtD
Gentamicin—Agranulocytosis—Dactinomycin—uterine cancer	0.00226	0.00457	CcSEcCtD
Gentamicin—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00224	0.00454	CcSEcCtD
Gentamicin—LRP2—Disease—RNF43—uterine cancer	0.00223	0.00479	CbGpPWpGaD
Gentamicin—Confusional state—Progesterone—uterine cancer	0.0022	0.00446	CcSEcCtD
Gentamicin—Anaphylactic shock—Progesterone—uterine cancer	0.00218	0.00442	CcSEcCtD
Gentamicin—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00218	0.00441	CcSEcCtD
Gentamicin—Injection site pain—Epirubicin—uterine cancer	0.00215	0.00435	CcSEcCtD
Gentamicin—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.00425	CcSEcCtD
Gentamicin—LRP2—Metabolism—STAR—uterine cancer	0.0021	0.0045	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AKR1B1—uterine cancer	0.0021	0.0045	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.00207	0.00445	CbGpPWpGaD
Gentamicin—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00418	CcSEcCtD
Gentamicin—Hypotension—Progesterone—uterine cancer	0.00204	0.00413	CcSEcCtD
Gentamicin—Extravasation—Epirubicin—uterine cancer	0.00201	0.00407	CcSEcCtD
Gentamicin—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00199	0.00404	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00199	0.00403	CcSEcCtD
Gentamicin—Injection site pain—Doxorubicin—uterine cancer	0.00199	0.00403	CcSEcCtD
Gentamicin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.004	CcSEcCtD
Gentamicin—Paraesthesia—Progesterone—uterine cancer	0.00196	0.00397	CcSEcCtD
Gentamicin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.00392	CcSEcCtD
Gentamicin—Alopecia—Dactinomycin—uterine cancer	0.00192	0.00389	CcSEcCtD
Gentamicin—Hypocalcaemia—Epirubicin—uterine cancer	0.00192	0.00388	CcSEcCtD
Gentamicin—Oliguria—Epirubicin—uterine cancer	0.0019	0.00385	CcSEcCtD
Gentamicin—Decreased appetite—Progesterone—uterine cancer	0.0019	0.00384	CcSEcCtD
Gentamicin—Erythema—Dactinomycin—uterine cancer	0.00189	0.00383	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—AKR1B10—uterine cancer	0.00189	0.00404	CbGpPWpGaD
Gentamicin—Extravasation—Doxorubicin—uterine cancer	0.00186	0.00377	CcSEcCtD
Gentamicin—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00185	0.00374	CcSEcCtD
Gentamicin—LRP2—Disease—AKR1C1—uterine cancer	0.00184	0.00394	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00365	CcSEcCtD
Gentamicin—Feeling abnormal—Progesterone—uterine cancer	0.0018	0.00364	CcSEcCtD
Gentamicin—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.0036	CcSEcCtD
Gentamicin—Hypocalcaemia—Doxorubicin—uterine cancer	0.00177	0.00359	CcSEcCtD
Gentamicin—Oliguria—Doxorubicin—uterine cancer	0.00176	0.00357	CcSEcCtD
Gentamicin—Anaemia—Dactinomycin—uterine cancer	0.00175	0.00354	CcSEcCtD
Gentamicin—Urticaria—Progesterone—uterine cancer	0.00173	0.00351	CcSEcCtD
Gentamicin—Body temperature increased—Progesterone—uterine cancer	0.00173	0.00349	CcSEcCtD
Gentamicin—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00348	CcSEcCtD
Gentamicin—Neuropathy peripheral—Etoposide—uterine cancer	0.00172	0.00347	CcSEcCtD
Gentamicin—Stomatitis—Etoposide—uterine cancer	0.00171	0.00346	CcSEcCtD
Gentamicin—Salivary hypersecretion—Epirubicin—uterine cancer	0.0017	0.00345	CcSEcCtD
Gentamicin—Leukopenia—Dactinomycin—uterine cancer	0.00169	0.00343	CcSEcCtD
Gentamicin—LRP2—Metabolism—POLD1—uterine cancer	0.00165	0.00353	CbGpPWpGaD
Gentamicin—Agranulocytosis—Etoposide—uterine cancer	0.00163	0.00331	CcSEcCtD
Gentamicin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.0033	CcSEcCtD
Gentamicin—Hypersensitivity—Progesterone—uterine cancer	0.00161	0.00326	CcSEcCtD
Gentamicin—LRP2—Disease—DCN—uterine cancer	0.00159	0.00341	CbGpPWpGaD
Gentamicin—Salivary hypersecretion—Doxorubicin—uterine cancer	0.00158	0.00319	CcSEcCtD
Gentamicin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00318	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—RNF43—uterine cancer	0.00156	0.00335	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Etoposide—uterine cancer	0.00156	0.00317	CcSEcCtD
Gentamicin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00317	CcSEcCtD
Gentamicin—Pruritus—Progesterone—uterine cancer	0.00154	0.00313	CcSEcCtD
Gentamicin—LRP2—Metabolism—AKR1C1—uterine cancer	0.00154	0.0033	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Dactinomycin—uterine cancer	0.00151	0.00306	CcSEcCtD
Gentamicin—Phlebitis—Epirubicin—uterine cancer	0.00148	0.00299	CcSEcCtD
Gentamicin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00295	CcSEcCtD
Gentamicin—Dizziness—Progesterone—uterine cancer	0.00144	0.00292	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—INHBA—uterine cancer	0.00143	0.00307	CbGpPWpGaD
Gentamicin—Vascular purpura—Epirubicin—uterine cancer	0.00142	0.00288	CcSEcCtD
Gentamicin—LRP2—Disease—AKR1C3—uterine cancer	0.00142	0.00303	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00141	0.00285	CcSEcCtD
Gentamicin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00283	CcSEcCtD
Gentamicin—Alopecia—Etoposide—uterine cancer	0.00139	0.00281	CcSEcCtD
Gentamicin—Vomiting—Progesterone—uterine cancer	0.00139	0.00281	CcSEcCtD
Gentamicin—LRP2—Disease—HMGA1—uterine cancer	0.00138	0.00296	CbGpPWpGaD
Gentamicin—Rash—Progesterone—uterine cancer	0.00138	0.00279	CcSEcCtD
Gentamicin—Dermatitis—Progesterone—uterine cancer	0.00137	0.00278	CcSEcCtD
Gentamicin—LRP2—Metabolism—RRM2—uterine cancer	0.00137	0.00294	CbGpPWpGaD
Gentamicin—Phlebitis—Doxorubicin—uterine cancer	0.00137	0.00277	CcSEcCtD
Gentamicin—Headache—Progesterone—uterine cancer	0.00137	0.00277	CcSEcCtD
Gentamicin—Decreased appetite—Dactinomycin—uterine cancer	0.00134	0.00272	CcSEcCtD
Gentamicin—LRP2—Metabolism—DCN—uterine cancer	0.00133	0.00286	CbGpPWpGaD
Gentamicin—Purpura—Epirubicin—uterine cancer	0.00132	0.00268	CcSEcCtD
Gentamicin—Vascular purpura—Doxorubicin—uterine cancer	0.00132	0.00267	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00132	0.00266	CcSEcCtD
Gentamicin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00265	CcSEcCtD
Gentamicin—Lethargy—Epirubicin—uterine cancer	0.0013	0.00263	CcSEcCtD
Gentamicin—Nausea—Progesterone—uterine cancer	0.0013	0.00263	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—AKR1C1—uterine cancer	0.00129	0.00276	CbGpPWpGaD
Gentamicin—Feeling abnormal—Dactinomycin—uterine cancer	0.00127	0.00257	CcSEcCtD
Gentamicin—Anaemia—Etoposide—uterine cancer	0.00126	0.00256	CcSEcCtD
Gentamicin—LRP2—Disease—FBXW7—uterine cancer	0.00126	0.0027	CbGpPWpGaD
Gentamicin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00255	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP11A1—uterine cancer	0.00126	0.00269	CbGpPWpGaD
Gentamicin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00253	CcSEcCtD
Gentamicin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00252	CcSEcCtD
Gentamicin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00251	CcSEcCtD
Gentamicin—Vertigo—Etoposide—uterine cancer	0.00123	0.00249	CcSEcCtD
Gentamicin—Leukopenia—Etoposide—uterine cancer	0.00122	0.00248	CcSEcCtD
Gentamicin—Purpura—Doxorubicin—uterine cancer	0.00122	0.00248	CcSEcCtD
Gentamicin—Body temperature increased—Dactinomycin—uterine cancer	0.00122	0.00247	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00122	0.00246	CcSEcCtD
Gentamicin—Lethargy—Doxorubicin—uterine cancer	0.0012	0.00243	CcSEcCtD
Gentamicin—LRP2—Metabolism—AKR1C3—uterine cancer	0.00119	0.00254	CbGpPWpGaD
Gentamicin—Convulsion—Etoposide—uterine cancer	0.00119	0.0024	CcSEcCtD
Gentamicin—Hypertension—Etoposide—uterine cancer	0.00118	0.00239	CcSEcCtD
Gentamicin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00238	CcSEcCtD
Gentamicin—Hypokalaemia—Epirubicin—uterine cancer	0.00116	0.00235	CcSEcCtD
Gentamicin—Hypersensitivity—Dactinomycin—uterine cancer	0.00114	0.0023	CcSEcCtD
Gentamicin—Confusional state—Etoposide—uterine cancer	0.00113	0.00228	CcSEcCtD
Gentamicin—Muscular weakness—Epirubicin—uterine cancer	0.00112	0.00227	CcSEcCtD
Gentamicin—Anaphylactic shock—Etoposide—uterine cancer	0.00112	0.00226	CcSEcCtD
Gentamicin—Thrombocytopenia—Etoposide—uterine cancer	0.00109	0.00221	CcSEcCtD
Gentamicin—Eosinophilia—Epirubicin—uterine cancer	0.00109	0.00221	CcSEcCtD
Gentamicin—Hypokalaemia—Doxorubicin—uterine cancer	0.00107	0.00217	CcSEcCtD
Gentamicin—Hypotension—Etoposide—uterine cancer	0.00104	0.00211	CcSEcCtD
Gentamicin—Muscular weakness—Doxorubicin—uterine cancer	0.00104	0.0021	CcSEcCtD
Gentamicin—Eosinophilia—Doxorubicin—uterine cancer	0.00101	0.00204	CcSEcCtD
Gentamicin—Paraesthesia—Etoposide—uterine cancer	0.001	0.00203	CcSEcCtD
Gentamicin—Weight decreased—Epirubicin—uterine cancer	0.000996	0.00202	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—AKR1C3—uterine cancer	0.000992	0.00212	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN2B—uterine cancer	0.000989	0.00212	CbGpPWpGaD
Gentamicin—Vomiting—Dactinomycin—uterine cancer	0.000981	0.00199	CcSEcCtD
Gentamicin—Rash—Dactinomycin—uterine cancer	0.000973	0.00197	CcSEcCtD
Gentamicin—Decreased appetite—Etoposide—uterine cancer	0.00097	0.00197	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PGR—uterine cancer	0.000967	0.00207	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Epirubicin—uterine cancer	0.000962	0.00195	CcSEcCtD
Gentamicin—Stomatitis—Epirubicin—uterine cancer	0.000956	0.00194	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000941	0.00202	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—STK11—uterine cancer	0.000924	0.00198	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP19A1—uterine cancer	0.000924	0.00198	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—YWHAE—uterine cancer	0.000922	0.00198	CbGpPWpGaD
Gentamicin—Weight decreased—Doxorubicin—uterine cancer	0.000921	0.00187	CcSEcCtD
Gentamicin—Feeling abnormal—Etoposide—uterine cancer	0.00092	0.00186	CcSEcCtD
Gentamicin—Nausea—Dactinomycin—uterine cancer	0.000916	0.00186	CcSEcCtD
Gentamicin—Agranulocytosis—Epirubicin—uterine cancer	0.000916	0.00185	CcSEcCtD
Gentamicin—LRP2—Disease—SMAD3—uterine cancer	0.000903	0.00193	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Doxorubicin—uterine cancer	0.00089	0.0018	CcSEcCtD
Gentamicin—Urticaria—Etoposide—uterine cancer	0.000887	0.0018	CcSEcCtD
Gentamicin—Stomatitis—Doxorubicin—uterine cancer	0.000885	0.00179	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—FBXW7—uterine cancer	0.000884	0.00189	CbGpPWpGaD
Gentamicin—Body temperature increased—Etoposide—uterine cancer	0.000882	0.00179	CcSEcCtD
Gentamicin—Hypoaesthesia—Epirubicin—uterine cancer	0.000876	0.00177	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000867	0.00186	CbGpPWpGaD
Gentamicin—LRP2—Disease—FGFR2—uterine cancer	0.000861	0.00185	CbGpPWpGaD
Gentamicin—Visual impairment—Epirubicin—uterine cancer	0.000849	0.00172	CcSEcCtD
Gentamicin—Agranulocytosis—Doxorubicin—uterine cancer	0.000847	0.00172	CcSEcCtD
Gentamicin—LRP2—Disease—MTHFR—uterine cancer	0.000829	0.00178	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000827	0.00177	CbGpPWpGaD
Gentamicin—Hypersensitivity—Etoposide—uterine cancer	0.000822	0.00167	CcSEcCtD
Gentamicin—Tinnitus—Epirubicin—uterine cancer	0.000821	0.00166	CcSEcCtD
Gentamicin—Hypoaesthesia—Doxorubicin—uterine cancer	0.000811	0.00164	CcSEcCtD
Gentamicin—Pruritus—Etoposide—uterine cancer	0.00079	0.0016	CcSEcCtD
Gentamicin—Visual impairment—Doxorubicin—uterine cancer	0.000785	0.00159	CcSEcCtD
Gentamicin—Alopecia—Epirubicin—uterine cancer	0.000778	0.00158	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—STK11—uterine cancer	0.000773	0.00166	CbGpPWpGaD
Gentamicin—Erythema—Epirubicin—uterine cancer	0.000767	0.00155	CcSEcCtD
Gentamicin—Tinnitus—Doxorubicin—uterine cancer	0.00076	0.00154	CcSEcCtD
Gentamicin—Dizziness—Etoposide—uterine cancer	0.000738	0.0015	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SOCS3—uterine cancer	0.000724	0.00155	CbGpPWpGaD
Gentamicin—Alopecia—Doxorubicin—uterine cancer	0.00072	0.00146	CcSEcCtD
Gentamicin—Vomiting—Etoposide—uterine cancer	0.00071	0.00144	CcSEcCtD
Gentamicin—Erythema—Doxorubicin—uterine cancer	0.000709	0.00144	CcSEcCtD
Gentamicin—Anaemia—Epirubicin—uterine cancer	0.000709	0.00144	CcSEcCtD
Gentamicin—Rash—Etoposide—uterine cancer	0.000704	0.00143	CcSEcCtD
Gentamicin—Dermatitis—Etoposide—uterine cancer	0.000703	0.00142	CcSEcCtD
Gentamicin—Headache—Etoposide—uterine cancer	0.000699	0.00142	CcSEcCtD
Gentamicin—LRP2—Metabolism—MTHFR—uterine cancer	0.000694	0.00149	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN2B—uterine cancer	0.000693	0.00148	CbGpPWpGaD
Gentamicin—Vertigo—Epirubicin—uterine cancer	0.000689	0.0014	CcSEcCtD
Gentamicin—Leukopenia—Epirubicin—uterine cancer	0.000686	0.00139	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—IGF1R—uterine cancer	0.000673	0.00144	CbGpPWpGaD
Gentamicin—Convulsion—Epirubicin—uterine cancer	0.000664	0.00135	CcSEcCtD
Gentamicin—Nausea—Etoposide—uterine cancer	0.000663	0.00134	CcSEcCtD
Gentamicin—Hypertension—Epirubicin—uterine cancer	0.000662	0.00134	CcSEcCtD
Gentamicin—Anaemia—Doxorubicin—uterine cancer	0.000656	0.00133	CcSEcCtD
Gentamicin—Arthralgia—Epirubicin—uterine cancer	0.000653	0.00132	CcSEcCtD
Gentamicin—Vertigo—Doxorubicin—uterine cancer	0.000637	0.00129	CcSEcCtD
Gentamicin—Leukopenia—Doxorubicin—uterine cancer	0.000635	0.00129	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SMAD3—uterine cancer	0.000632	0.00135	CbGpPWpGaD
Gentamicin—Confusional state—Epirubicin—uterine cancer	0.000631	0.00128	CcSEcCtD
Gentamicin—Anaphylactic shock—Epirubicin—uterine cancer	0.000626	0.00127	CcSEcCtD
Gentamicin—Convulsion—Doxorubicin—uterine cancer	0.000615	0.00124	CcSEcCtD
Gentamicin—Thrombocytopenia—Epirubicin—uterine cancer	0.000613	0.00124	CcSEcCtD
Gentamicin—Hypertension—Doxorubicin—uterine cancer	0.000612	0.00124	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000612	0.00131	CbGpPWpGaD
Gentamicin—Arthralgia—Doxorubicin—uterine cancer	0.000604	0.00122	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—FGFR2—uterine cancer	0.000603	0.00129	CbGpPWpGaD
Gentamicin—Hypotension—Epirubicin—uterine cancer	0.000585	0.00118	CcSEcCtD
Gentamicin—Confusional state—Doxorubicin—uterine cancer	0.000584	0.00118	CcSEcCtD
Gentamicin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000579	0.00117	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00057	0.00115	CcSEcCtD
Gentamicin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000567	0.00115	CcSEcCtD
Gentamicin—Paraesthesia—Epirubicin—uterine cancer	0.000562	0.00114	CcSEcCtD
Gentamicin—Decreased appetite—Epirubicin—uterine cancer	0.000544	0.0011	CcSEcCtD
Gentamicin—Hypotension—Doxorubicin—uterine cancer	0.000541	0.0011	CcSEcCtD
Gentamicin—LRP2—Disease—ERBB2—uterine cancer	0.000541	0.00116	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000528	0.00107	CcSEcCtD
Gentamicin—Paraesthesia—Doxorubicin—uterine cancer	0.00052	0.00105	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ESR1—uterine cancer	0.000516	0.00111	CbGpPWpGaD
Gentamicin—Feeling abnormal—Epirubicin—uterine cancer	0.000516	0.00104	CcSEcCtD
Gentamicin—Decreased appetite—Doxorubicin—uterine cancer	0.000503	0.00102	CcSEcCtD
Gentamicin—LRP2—Disease—CDKN1B—uterine cancer	0.000501	0.00107	CbGpPWpGaD
Gentamicin—Urticaria—Epirubicin—uterine cancer	0.000497	0.00101	CcSEcCtD
Gentamicin—Body temperature increased—Epirubicin—uterine cancer	0.000495	0.001	CcSEcCtD
Gentamicin—Feeling abnormal—Doxorubicin—uterine cancer	0.000477	0.000966	CcSEcCtD
Gentamicin—LRP2—Disease—CTNNB1—uterine cancer	0.000473	0.00101	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTEN—uterine cancer	0.000461	0.000988	CbGpPWpGaD
Gentamicin—Hypersensitivity—Epirubicin—uterine cancer	0.000461	0.000934	CcSEcCtD
Gentamicin—Urticaria—Doxorubicin—uterine cancer	0.00046	0.000932	CcSEcCtD
Gentamicin—Body temperature increased—Doxorubicin—uterine cancer	0.000458	0.000927	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCL2—uterine cancer	0.000454	0.000973	CbGpPWpGaD
Gentamicin—Pruritus—Epirubicin—uterine cancer	0.000443	0.000897	CcSEcCtD
Gentamicin—LRP2—Disease—EP300—uterine cancer	0.00044	0.000942	CbGpPWpGaD
Gentamicin—Hypersensitivity—Doxorubicin—uterine cancer	0.000427	0.000864	CcSEcCtD
Gentamicin—Dizziness—Epirubicin—uterine cancer	0.000414	0.000838	CcSEcCtD
Gentamicin—LRP2—Disease—NRAS—uterine cancer	0.000412	0.000882	CbGpPWpGaD
Gentamicin—Pruritus—Doxorubicin—uterine cancer	0.00041	0.00083	CcSEcCtD
Gentamicin—Vomiting—Epirubicin—uterine cancer	0.000398	0.000806	CcSEcCtD
Gentamicin—Rash—Epirubicin—uterine cancer	0.000395	0.000799	CcSEcCtD
Gentamicin—Dermatitis—Epirubicin—uterine cancer	0.000394	0.000798	CcSEcCtD
Gentamicin—Headache—Epirubicin—uterine cancer	0.000392	0.000794	CcSEcCtD
Gentamicin—LRP2—Metabolism—PTEN—uterine cancer	0.000386	0.000828	CbGpPWpGaD
Gentamicin—Dizziness—Doxorubicin—uterine cancer	0.000383	0.000775	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ERBB2—uterine cancer	0.000379	0.000811	CbGpPWpGaD
Gentamicin—Nausea—Epirubicin—uterine cancer	0.000372	0.000753	CcSEcCtD
Gentamicin—LRP2—Metabolism—EP300—uterine cancer	0.000368	0.000789	CbGpPWpGaD
Gentamicin—Vomiting—Doxorubicin—uterine cancer	0.000368	0.000746	CcSEcCtD
Gentamicin—Rash—Doxorubicin—uterine cancer	0.000365	0.000739	CcSEcCtD
Gentamicin—Dermatitis—Doxorubicin—uterine cancer	0.000365	0.000739	CcSEcCtD
Gentamicin—Headache—Doxorubicin—uterine cancer	0.000363	0.000735	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CXCL8—uterine cancer	0.000359	0.00077	CbGpPWpGaD
Gentamicin—LRP2—Disease—KRAS—uterine cancer	0.000354	0.000759	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN1B—uterine cancer	0.000351	0.000752	CbGpPWpGaD
Gentamicin—Nausea—Doxorubicin—uterine cancer	0.000344	0.000696	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CTNNB1—uterine cancer	0.000331	0.00071	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CA—uterine cancer	0.000325	0.000697	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTEN—uterine cancer	0.000323	0.000692	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EP300—uterine cancer	0.000308	0.00066	CbGpPWpGaD
Gentamicin—LRP2—Disease—HRAS—uterine cancer	0.000301	0.000645	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFA—uterine cancer	0.000292	0.000625	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NRAS—uterine cancer	0.000288	0.000617	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CA—uterine cancer	0.000273	0.000584	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT1—uterine cancer	0.000266	0.000569	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KRAS—uterine cancer	0.000248	0.000531	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CA—uterine cancer	0.000228	0.000488	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AKT1—uterine cancer	0.000223	0.000477	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—uterine cancer	0.00022	0.000472	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HRAS—uterine cancer	0.000211	0.000452	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT1—uterine cancer	0.000186	0.000399	CbGpPWpGaD
